Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy

Thyroid

Volumn 6, Issue 3, 1996, Pages 161-168

  Langdahl, Bente L ^a   Loft, Anne Gitte R ^a   Eriksen, Erik F ^a   Mosekilde, Leif ^a   Charles, Peder ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; HYDROXYPROLINE; LEVOTHYROXINE SODIUM; MAGNESIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE MASS; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; MAGNESIUM BLOOD LEVEL; MALE; MENOPAUSE; PHOSPHATE BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL; URINARY EXCRETION;

BIOLOGICAL MARKERS; BODY COMPOSITION; BONE DENSITY; BONE REMODELING; CALCIUM; HOMEOSTASIS; HUMANS; HYPERTHYROIDISM; PHOSPHATES; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0029762843     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Recklinghausen FCv 1891 Die Fibrose oder deformierende ostitis, die osteomalazie und die osteoplastische karzinose in ihren gegenseitigen beziehungen. In: Reimer G (ed) Festschrift Rudolpf Virchow, Berlin, pp. 1-89.
2. Eriksen EF, Mosekilde L, Melsen F 1985 Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6:421-428.
3. Meunier PJ, Bianchi GGS, Edouard CM, Bernard JC, Courpron P, Vignon GE 1972 Bony manifestations of thyrotoxicosis. Orthop Clin North Am 3(3):745-774.
4. Melsen F, Mosekilde L 1977 Morphometric and dynamic studies of bone changes in hyperthyroidism. Acta Path Micro Scan 85:141-150.
5. Fallon MD, Perry HM III, Bergfeld M, Droke D, Teitelbaum SL, Avioli LV 1983 Exogenous hyperthyroidism with osteoporosis. Arch Intern Med 143:442-444.
6. Smith DA, Fraser SA, Wilson GM 1973 Hyperthyroidism and calcium metabolism. Clin Endocr Metab 2(2):333-354.
7. Auwerx J, Bouillon R 1986 Mineral and bone metabolism in thyroid disease: A review. Q J Med 60(232):737-752.
8. Allain TJ, McGregor AM 1993 Thyroid hormones and bone. J Endocrinol 139(1):9-18.
9. Mosekilde L, Jastrup B, Melsen F, Lund B, Lund B, Sørensen OH, Nielsen HE 1984 Effect of propranolol treatment on bone mass, bone mineral content, bone remodelling, parathyroid function and vitamin D metabolism. Eur J Clin Invest 14:96-102.
10. Kragstrup J, Melsen F, Mosekilde L 1981 Effects of thyroid hormones on mean wall thickness of trabecular bone packets. Met Bone Dis Rel Res 3:181-186.
11. Mosekilde L, Melsen F, Bagger JP, Myhre-Jensen O, Sørensen NS 1977 Bone changes in hyperthyroidism: Interrelationships between bone morphometry, thyroid function and calciumphosphorus metabolism. Acta Endocrinol 85:515-525.
12. Mosekilde L, Melsen F 1978 A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand 204:97-102.
13. Mosekilde L, Eriksen EF, Charles P 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19(1):35-63.
14. Hattner R, Frost HM 1963 Mean skeletal age; its calculation, and theoretical effects on skeletal tracer physiology and on the physical characteristics on bone. Henry Ford Hospital Medic Bull 11:201-216.
15. Meema HE, Meema S 1972 Comparison of microradiograscopic and morphometric findings in the hand bones with densitometric findings in the proximal radius in thyrotoxicosis and in renal osteodystrophy. Invest Radiol 7:88-96.
16. Toh SH, Claunch BC, Brown PH 1985 Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145:883-886.
17. Nielsen HE, Mosekilde L, Charles P 1979 Bone mineral content in hyperthyroid patients after combined medical and surgical treatment. Acta Radiol Oncol 18(2):122-128.
18. Fraser SA, Anderson JB, Smith DA, Wilson GM 1971 Osteoporosis and fractures following thyrotoxicosis. Lancet 1:981-983.
19. Toh SH, Brown PH 1990 Bone mineral content in hypothyroid male patients with hormone replacement: A 3-year study. J Bone Min Res 5(5):463-467.
20. Linde J, Friis T 1979 Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol 91:437-448.
21. Bayley TA, Harrison JE, McNeill KG, Mernagh JR 1980 Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J Clin Endocrinol Metab 50(5):916-922.
22. Földes J, Tarján G, Szathmari M, Varga F, Krasznai I, Horvath C 1993 Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis. Clin Endocrinol Oxf 39(5): 521-527.
23. Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh C-S, Min HK 1990 Negative correlations between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 70(3):766-770.
24. Krølner B, Jørgensen JV, Nielsen SP 1983 Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol Oxf 18:439-446.
25. Rosen CJ, Adler RA 1992 Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75(6):1531-1534.
26. Cooper C, Shah S, Hand DJ, Adams J, Compston J, Davie M, Wolf A.1991 Screening for vertebral osteoporosis using individual risk factors. The multicenter fracture study group. Osteoporosis Int 2(1):48-53.
27. Solomon BL, Wartofsky L, Burman KD 1993 Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 3(1):17-23.
28. Arnaud CD, Pun KK 1992 Metabolism and assay of parathyroid hormone, Chap. 5. In: Coe FL, Favus MJ (eds) Disorders of Bone and Mineral Metabolism. Raven Press, New York.
29. Habener JF, Potts JT Jr 1990 Fundamental consideration in the physiology, biology and biochemistry of parathyroid hormone, Chap. 3. In: Avioli LV, Krane SM (eds) Metabolic Bone Disease, 2nd ed. W.B. Saunders, Philadelphia.
30. Risteli J, Niemi S, Elomaa T, Risteli L 1991 Bone resorption assay based on a peptide liberated during type I collagen degradation. J Bone Min Res 6:S251.
31. Black D, Duncan A, Robins SP 1988 Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reverse-phase high-performance liquid chromatography. Anal Biochem 169:197-203.
32. Eyre DR, Koob TJ, Von Ness KP 1984 Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 137:380-388.
33. Brixen K, Nielsen HK, Eriksen EF 1989 Efficacy of wheat germ lectin precipitated alkaline phosphatase in serum as an estimate of bone mineralization rate: Comparison to serum alkaline phosphatase and serum bone gla protein. Calcif Tissue Int 44:93-98.
34. Nielsen HK, Laurberg P, Brixen K, Mosekilde L 1991 Relation between the diurnal variation in serum osteocalcin, and the variation in serum concentrations of cortisol, PTH(1-84) and ionized calcium in normal individuals. Acta Endocrinol 124:391-398.
35. Melkko J, Niemi S, Risteli L, Risteli J 1990 Radioimmunoassay for the carboxyterminal propetide of human type I procollagen. Clin Chem 36:1328-1332.
36. Bland JM, Altman DG 1995 Multiple significance tests: The Bonferroni method. Br Med J 310:170.
37. Mosekilde L, Christensen MS, Melsen F, Sørensen NS 1978 Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism: I: Chemical quantities in serum and urine. Acta Endocrinol 87:743-750.
38. MacLeod JM, McHardy KC, Harvey RD, Duncan A, Reid IW, Bewster PD, Robins SP 1993 The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin Endocrinol Oxf 38(1):49-53.
39. Lalau JD, Selbert JL, Maris A, Fournier A, Quichard J 1986 Effects of thyrotoxicosis and its treatment on mineral and bone metabolism. J Endocrinol Invest 9:491-496.
40. Bijlsma JSJ, Duursma SA, Roelofs JMM, Kinderen PJd 1983 Thyroid function and bone turnover. Acta Endocrinol 104:42-49.
41. Mosekilde L, Melsen F 1978 Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism: II. Bone histomorphometry. Acta Endocrinol 87:751-758.
42. Christiansen P, Steiniche T, Mosekilde L, Hessov I, Melsen F 1990 Primary hyperparathyroidism: Changes in trabecular bone remodeling following surgical treatment - evaluated by histomorphometric methods. Bone 11:75-79.
43. Siersbask-Nielsen K, Skovsted L, Hansen JM, Kristensen M, Christensen LK 1971 Hydroxyproline excretion in the urine and calcium metabolism during long-term treatment of thyrotoxicosis with propylthiouracil. Acta Med Scand 189:485-488.
44. Parfitt AM 1984 The cellular basis of bone remodelling: The quantum concept reexamined in the light of recent advances in the cell biology of bone. Calcif Tissue Int 36:37-45.
45. Lowery W, Thomas C, Awbrey B, Rosenstein B, Talmage R 1986 The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease. Surgery 100:1142-1149.
46. Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF 1992 Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J Clin Endocrinol Metab 75(1):45-51.
47. Judd HL, Lucas WE, Yen SS 1976 Serum 17 beta-estradiol, and estrone levels in postmenopausal women with and without endometrial cancer, J Clin Endocrinol Metab 43(2):272-278.
48. Vermeulen A 1980 Sex hormone status of the postmenopausal woman. Maturitas 2(2):81-89.
49. Deslypere JP, Verdonck L, Vermeulen A 1985 Fat tissue: A steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab 61(3):564-570.
50. Mosekilde L, Melsen F 1978 Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Path Micro Scan 86:56-62.
51. Deftos LJ 1993 Calcitonin. In: Favus MJ (ed) Primer on the Metabolice Bone Diseases and Disorders of Mineral Metabolism, 2nd ed, Raven Press, New York, pp. 70-76.
52. Busnardo B, Zannata GP, Simioni N, Busetto E, Viaro A, Girelli ME 1983 Calcitonin and parathyroid hormone relationships in thyrotoxicosis. Acta Endocrinol 256(Suppl.):133.
53. Zanatta GP, Simini N, Girelli ME, Nacamulli D, Busnardo B 1984 Parathyroid hormone and calcitonin in thyrotoxicosis. Horm Metab Res 16:384.
54. Reid IR, Plank LD, Evans MC 1992 Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75(3):779-782.